IBA posts healthy revenue for fiscal 2016
Proton therapy developer Ion Beam Applications (IBA) has posted healthy revenue...Read more on AuntMinnie.comRelated Reading: IBA, partners to bring proton therapy to Ala. IBA, Nelco ink North American deal Japan OKs IBA's proton therapy system IBA reaches treatment milestone, wins UAE order IBA wins proton therapy contract in China (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 23, 2017 Category: Radiology Source Type: news

Proton Therapy Improves Outcomes in Recurrent Lung Cancer Proton Therapy Improves Outcomes in Recurrent Lung Cancer
Reirradiation with intensity-modulated proton therapy appears safe and improved outcomes in patients with recurrent lung cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 22, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Proton Therapy Reirradiation Safe, Effective for Recurrent Thoracic Tumors
The use of reirradiation with intensity-modulated proton therapy yielded strong overall survival with limited toxicity in patients with thoracic tumors, potentially offering a new option in this patient population. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Lung Cancer News Source Type: news

Advanced form of proton therapy shows promise for treating lung cancer recurrence
An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment of recurrent lung cancer, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 17, 2017 Category: Science Source Type: news

Advanced form of proton therapy shows promise for treating lung cancer recurrence
(University of Texas M. D. Anderson Cancer Center) An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment of recurrent lung cancer, according to new research from The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 17, 2017 Category: Cancer & Oncology Source Type: news